Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model

Botulinum neurotoxin (BoNT) serotypes A, B and E are responsible for most cases of human botulism. The only approved therapy for botulism is antitoxin treatment administered to patients after symptom onset. However, a recent meta-analysis of antitoxin efficacy in human botulism cases over the past c...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Dis Model Mech
Päätekijät: Torgeman, Amram, Schwartz, Arieh, Diamant, Eran, Baruchi, Tzadok, Dor, Eyal, Ben David, Alon, Pass, Avi, Barnea, Ada, Tal, Arnon, Rosner, Amir, Rosen, Osnat, Zichel, Ran
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Company of Biologists Ltd 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6177009/
https://ncbi.nlm.nih.gov/pubmed/30115749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1242/dmm.035089
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia